218 related articles for article (PubMed ID: 20708521)
1. Insertion of the Mirena intrauterine system for treatment of adenomyosis-associated menorrhagia: a novel method.
Peng FS; Wu MY; Yang JH; Chen SU; Ho HN; Yang YS
Taiwan J Obstet Gynecol; 2010 Jun; 49(2):160-4. PubMed ID: 20708521
[TBL] [Abstract][Full Text] [Related]
2. [Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis].
Sheng J; Lu D; Zhang JP; Cui GF
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):467-70. PubMed ID: 17083813
[TBL] [Abstract][Full Text] [Related]
3. Two for the price of one.
Samuel MI; Tenant-Flowers M; Kumar U; Taylor C
Int J STD AIDS; 2008 Oct; 19(10):719-20. PubMed ID: 18824630
[TBL] [Abstract][Full Text] [Related]
4. Levonorgestrel-releasing intrauterine system: uses and controversies.
Bahamondes L; Bahamondes MV; Monteiro I
Expert Rev Med Devices; 2008 Jul; 5(4):437-45. PubMed ID: 18573044
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging.
Bragheto AM; Caserta N; Bahamondes L; Petta CA
Contraception; 2007 Sep; 76(3):195-9. PubMed ID: 17707716
[TBL] [Abstract][Full Text] [Related]
6. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and tolerability of levonorgestrel intrauterine system in adolescents.
Aslam N; Blunt S; Latthe P
J Obstet Gynaecol; 2010; 30(5):489-91. PubMed ID: 20604653
[TBL] [Abstract][Full Text] [Related]
8. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
9. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
Fedele L; Bianchi S; Raffaelli R; Portuese A; Dorta M
Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908
[TBL] [Abstract][Full Text] [Related]
10. Use of a levonorgestrel-releasing intrauterine device in the treatment of adenomyosis associated heavy menstrual bleeding.
Uysal A; Taner CE; Mun S; Uysal F; Celimli FH
J Pak Med Assoc; 2013 Nov; 63(11):1349-52. PubMed ID: 24392517
[TBL] [Abstract][Full Text] [Related]
11. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.
Rose S; Chaudhari A; Peterson CM
Adv Drug Deliv Rev; 2009 Aug; 61(10):808-12. PubMed ID: 19445984
[TBL] [Abstract][Full Text] [Related]
12. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
Sheng J; Zhang WY; Zhang JP; Lu D
Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
[TBL] [Abstract][Full Text] [Related]
13. Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
Rizkalla HF; Higgins M; Kelehan P; O'Herlihy C
Int J Gynecol Pathol; 2008 Jan; 27(1):74-8. PubMed ID: 18156979
[TBL] [Abstract][Full Text] [Related]
14. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA
J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768
[TBL] [Abstract][Full Text] [Related]
15. Medicated intrauterine systems for treatment of endometriosis-associated pain.
Muzii L
J Minim Invasive Gynecol; 2006; 13(6):535-8. PubMed ID: 17097576
[TBL] [Abstract][Full Text] [Related]
16. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.
Crosignani PG; Vercellini P; Mosconi P; Oldani S; Cortesi I; De Giorgi O
Obstet Gynecol; 1997 Aug; 90(2):257-63. PubMed ID: 9241305
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of levonorgestrel-releasing intrauterine system for adenomyosis].
He SM; Zhang YD
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1794-6. PubMed ID: 17259122
[TBL] [Abstract][Full Text] [Related]
18. Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis.
Ozdegirmenci O; Kayikcioglu F; Akgul MA; Kaplan M; Karcaaltincaba M; Haberal A; Akyol M
Fertil Steril; 2011 Feb; 95(2):497-502. PubMed ID: 21074150
[TBL] [Abstract][Full Text] [Related]
19. Re: The use of levonorgestrel-releasing intrauterine system for the treatment of menorrhagia in women with inherited bleeding disorders.
Curtis R; Inki P
BJOG; 2006 Feb; 113(2):248-9. PubMed ID: 16412011
[No Abstract] [Full Text] [Related]
20. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis.
Cho S; Nam A; Kim H; Chay D; Park K; Cho DJ; Park Y; Lee B
Am J Obstet Gynecol; 2008 Apr; 198(4):373.e1-7. PubMed ID: 18177833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
